Page 1 of 1

Patients should remain in isolation

Posted: Sun Feb 02, 2025 8:45 am
by zakiyatasnim
Antiviral drugs are generally not needed after discharge. Symptomatic treatment may be used if patients have mild cough, poor appetite, tongue coating, etc. Antiviral drugs may be used after discharge in patients with multiple lung lesions within the first 3 days after a negative nucleic acid amplification test result.

3 Home isolation

for two weeks after discharge. Recommended home isolation conditions:

Separate living area with frequent ventilation japan number data and disinfection;
Avoid contact with young children, the elderly, and people with weakened immune systems at home;
Patients and their family members should wear masks and wash their hands as often as possible;
Body temperature is measured twice a day (morning and evening) and any changes in the patient's condition are closely monitored.
4 Follow-up

A specialized physician should be assigned for each follow-up of the discharged patient. The first follow-up is conducted within 48 hours after discharge. Outpatient follow-up is conducted at 1 week, 2 weeks and 1 month after discharge. The examinations include liver and kidney function, blood test, nucleic acid amplification test of sputum and stool samples, and pulmonary function test or CT scan of the lungs, which should be checked according to the patient's condition. Follow-up phone calls are made at 3 and 6 months after discharge to check the patient's condition.

5 Management of patients with repeated positive reaction after discharge

Our hospital has implemented strict discharge standards. No patient has been discharged in our hospital whose sputum and stool samples tested positive again on follow-up examinations. However, there are a few reported cases of patients testing positive again after discharge according to national guidelines (negative results from at least two consecutive throat swabs collected 24 hours apart; normal body temperature for 3 days, symptoms have improved significantly; obvious resolution of inflammation on lung imaging). This is mainly due to sampling errors and false negative test results. The following strategies are recommended for such patients: